Skip to main content

Table 1 Baseline Characteristics

From: CpG increases vaccine antigen-specific cell-mediated immunity when administered with hepatitis B vaccine in HIV infection

 

Engerix-B

n = 19

Engerix B-CPG

N = 19

Male (n)

18

14

Prior Vaccine Failure (n)

10

9

Age (Mean ± SD)

42.9 ± 7.3

41.0 ± 7.4

CD4+ T cell count (Mean ± SD)

543 ± 228

647 ± 262

Proportion with HIV RNA <50 copies/mL

100%

100%